Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Robert-Koch Str. 3, 79106, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
Strahlenther Onkol. 2022 Jun;198(6):537-546. doi: 10.1007/s00066-022-01916-3. Epub 2022 Mar 31.
PURPOSE: Hippocampus-avoidance whole brain radiotherapy with simultaneous integrated boost (HA-WBRT+SIB) is a complex treatment option for patients with multiple brain metastases, aiming to prevent neurocognitive decline and simultaneously increase tumor control. Achieving efficient hippocampal dose reduction in this context can be challenging. The aim of the current study is to present and analyze the efficacy of complete directional hippocampal blocking in reducing the hippocampal dose during HA-WBRT+SIB. METHODS: A total of 30 patients with multiple metastases having undergone HA-WBRT+SIB were identified. The prescribed dose was 30 Gy in 12 fractions to the whole brain, with 98% of the hippocampus receiving ≤ 9 Gy and 2% ≤ 17 Gy and with SIB to metastases/resection cavities of 36-51 Gy in 12 fractions. Alternative treatment plans were calculated using complete directional hippocampal blocking and compared to conventional plans regarding target coverage, homogeneity, conformity, dose to hippocampi and organs at risk. RESULTS: All alternative plans reached prescription doses. Hippocampal blocking enabled more successful sparing of the hippocampus, with a mean dose of 8.79 ± 0.99 Gy compared to 10.07 ± 0.96 Gy in 12 fractions with the conventional method (p < 0.0001). The mean dose to the whole brain (excluding metastases and hippocampal avoidance region) was 30.52 ± 0.80 Gy with conventional planning and 30.28 ± 0.11 Gy with hippocampal blocking (p = 0.11). Target coverage, conformity and homogeneity indices for whole brain and metastases, as well as doses to organs at risk were similar between planning methods (p > 0.003). CONCLUSION: Complete directional hippocampal blocking is an efficient method for achieving improved hippocampal sparing during HA-WBRT+SIB.
目的:海马回避全脑放疗联合同步整合推量(HA-WBRT+SIB)是一种治疗多发脑转移瘤的复杂治疗方案,旨在预防神经认知功能下降的同时提高肿瘤控制率。在这种情况下,实现高效的海马剂量减少是具有挑战性的。本研究的目的是介绍并分析在 HA-WBRT+SIB 中完全定向性海马阻断降低海马剂量的疗效。
方法:共纳入 30 例接受 HA-WBRT+SIB 治疗的多发脑转移瘤患者。全脑处方剂量为 30Gy/12f,98%的海马接受剂量≤9Gy,2%的海马接受剂量≤17Gy,转移瘤/切除腔 SIB 剂量为 36-51Gy/12f。计算并比较了采用完全定向性海马阻断的替代治疗计划与常规计划在靶区覆盖、均匀性、适形性、海马剂量和危及器官剂量方面的差异。
结果:所有替代计划均达到了处方剂量。海马阻断能更成功地保护海马,12 分次时,阻断组的平均海马剂量为 8.79±0.99Gy,而常规组为 10.07±0.96Gy(p<0.0001)。全脑(不包括转移瘤和海马回避区)的平均剂量,常规组为 30.52±0.80Gy,阻断组为 30.28±0.11Gy(p=0.11)。两种计划方法的全脑和转移瘤靶区覆盖、适形性和均匀性指数以及危及器官剂量相似(p>0.003)。
结论:完全定向性海马阻断是一种在 HA-WBRT+SIB 中实现更好的海马保护的有效方法。
Int J Radiat Oncol Biol Phys. 2012-4-18
Phys Med Biol. 2023-12-1
Contrast Media Mol Imaging. 2022
Strahlenther Onkol. 2020-3-23